USPTO serial 79140021
FIS
Reviewed by CopyMark Law Group
Reg. 4619196Status 706Registered
- Filing date
- Status date
- Registration date
- Oct 14, 2014
- Examiner
- MCDOWELL, MATTHEW J
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with FIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
PORDENONE (PN), IT
IT
PORDENONE (PN), IT
F.I.S. FABBRICA ITALIANA SINTETICI S.p.A.
MONTECCHIO MAGGIORE (VI), IT
Other trademarks owned by F.I.S. FABBRICA ITALIANA SINTETICI S.p.A.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Leonard
Michael J. Leonard Fox Rothschild LLP212 Carnegie Center, Suite 400Princeton, NJ 08540United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | [ Soaps for personal use; perfumery, essential oils, cosmetics, hair lotions; dentifrices, abrasives, namely, skin abrasive preparations; scented linen water; aromatics, namely, essential oils; depilatory wax; hair dyes; cosmetic creams; deodorants for human beings or for animals; massage gels other than for medical purposes; hair spray; lotions for cosmetic purposes; lip glosses; cotton wool for cosmetic purposes; pumice stone for personal use; pomades for cosmetic purposes; potpourris in the nature of fragrances; nail care preparations; non-medicated toiletries; perfumes; air fragrancing preparations; shampoos; sunscreen preparations ] | SECTION 71 - CANCELLED | — |
| 005 | [ Pharmaceutical preparations, namely, drugs for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; veterinary preparations, namely, drugs for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs, for domestic, farm and marine animals; sanitary preparations for medical purposes; substances for supplements adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; medical plasters; materials for dressings, namely, medical and surgical dressings; material for stopping teeth, dental wax; acids for pharmaceutical purposes, namely, amino acids; thermal water for medical purposes, namely, nutritionally fortified water; nutritional supplements; medicinal alcohol; anaesthetics; fumigating sticks; antibiotics; antioxidant pills; antiseptics; sanitary towels; bath preparations, medicated; balms for medical purposes; medicated confectionery; sticking plasters for medical use; adjuvants for medical purposes; collyrium; medicated compresses; chemical contraceptives; cultures of microorganisms for medical and veterinary use; depuratives for the body; digestives for pharmaceutical purposes; drugs for medical purposes, namely, drugs for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; medicinal herbs; medicinal fungi; meal for pharmaceutical purposes; febrifuges; milk ferments for pharmaceutical purposes; chewing gum for medical purposes; insecticides; insect repellents; dietary and nutritional supplements; vitamin supplement products, namely, vitamin supplements; mineral food supplements; nutritional supplements for medical purposes; protein dietary supplements; mineral food supplements; laxatives; lotions for pharmaceutical purposes; skin lotions for veterinary purposes; medicines for human purposes, namely, medicines for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; medicines for dental purposes; medicines for veterinary purposes, namely, drugs for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs, for domestic, farm and marine animals; serotherapeutic medicines; medicinal oils; royal jelly dietary supplements; parasiticides; lozenges for pharmaceutical purposes; pesticides; medical slimming pills; pomades for medical purposes; biological preparations for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs, for veterinary purposes, for domestic, farm and marine animals; chemical preparations for pharmaceutical purposes, namely, for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; chemical preparations for medical purposes, namely, for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; chemical preparations for veterinary purposes, namely, for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; bacterial preparations for medical and veterinary use; bacteriological preparations for medical and veterinary use; vitamin preparations; hemorrhoid treatment preparations; antiparasitic preparations; mothproofing preparations; anti-uric preparations; biological preparations, namely, for treatment of diseases or having properties active in the following organs or therapeutic fields: alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, dermatological drugs, genitourinary system and reproductive hormones, systemic hormonal preparations, excluding reproductive hormones and insulins, antiinfectives for systemic use, antineoplastic and immunomodulating agents, musculoskeletal system, nervous system, antiparasitic products, insecticides and repellents, respiratory system, sensory organs; pharmaceutical preparations for skin care; diagnostic preparations for medical purposes; air purifying preparations; radioactive substances for medical purposes; sodium salts for medical purposes; serums for treatment of skin, lips, hair; soporifics; radiological contrast substances for medical purposes; dietetic substances adapted for medical use, namely, dietary supplements; herbal teas for medicinal purposes; vaccines; vermifuges, namely, medicines for expelling intestinal worms ] | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, pharmaceutical, chemical, biotechnology research and development; industrial analysis and research services in the fields of pharmaceutical [ and cosmetics ] ; chemical analysis; [ material testing; industrial design; designing and conducting geological surveys; ] [ conducting clinical trials for others; ] [ geological prospecting; ] biological research; [ geological research; ] [ bacteriological research; ] chemical research; [ cosmetic research; physics research; research in the field of environmental protection; mechanical research; ] scientific research; technical research in the fields of pharmaceuticals, chemicals, and biotechnologies; chemistry services, namely, chemistry research and chemistry consultation; scientific laboratory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HOLDING F.I.S. S.P.A.
- Other trademarks owned by NINE TREES GROUP S.P.A.
- Other trademarks owned by HOLDING F.I.S. S.P.A.
- Other trademarks owned by F.I.S. FABBRICA ITALIANA SINTETICI S.p.A.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named FIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 26, 2026 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 26, 2026 | INPC | INVALIDATION PROCESSED | — |
| Dec 7, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 7, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Apr 7, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Apr 7, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 5, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jun 21, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Mar 29, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 14, 2023 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Oct 9, 2023 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jul 7, 2023 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jun 4, 2023 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 28, 2022 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 21, 2022 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 21, 2022 | INPC | INVALIDATION PROCESSED | — |
| Apr 6, 2022 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 6, 2021 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Aug 6, 2021 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Aug 6, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 14, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 1, 2021 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Aug 1, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 31, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 16, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 11, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 11, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 14, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 14, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 29, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 24, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 9, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 9, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 9, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 26, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 25, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 12, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 4, 2014 | ALIE | ASSIGNED TO LIE | — |
| May 22, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 2, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 2, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 29, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 28, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 23, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 23, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 19, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |